Lawrence Levine

497 total citations
8 papers, 415 citations indexed

About

Lawrence Levine is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lawrence Levine has authored 8 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lawrence Levine's work include Marine Toxins and Detection Methods (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Animal Ecology and Behavior Studies (1 paper). Lawrence Levine is often cited by papers focused on Marine Toxins and Detection Methods (2 papers), Inflammatory mediators and NSAID effects (2 papers) and Animal Ecology and Behavior Studies (1 paper). Lawrence Levine collaborates with scholars based in United States and Japan. Lawrence Levine's co-authors include Stephen L. Swartz, Robert G. Dluhy, Norman K. Hollenberg, Gordon H. Williams, Thomas J. Moore, Armen H. Tashjian, Paul L. Munson, David Sheṕro, Herbert B. Hechtman and Michael M. Krausz and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Lawrence Levine

8 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Levine United States 6 209 118 70 64 64 8 415
Jiří Heller Czechia 12 211 1.0× 111 0.9× 32 0.5× 113 1.8× 29 0.5× 24 388
Takehiro Igawa Japan 10 211 1.0× 142 1.2× 68 1.0× 46 0.7× 16 0.3× 20 562
J Nussberger Switzerland 10 310 1.5× 122 1.0× 55 0.8× 140 2.2× 58 0.9× 36 475
E. Podjarny Israel 14 115 0.6× 71 0.6× 107 1.5× 71 1.1× 40 0.6× 48 707
N. Papanicolaou France 13 141 0.7× 119 1.0× 134 1.9× 96 1.5× 39 0.6× 38 547
C Werning Germany 11 92 0.4× 88 0.7× 140 2.0× 140 2.2× 24 0.4× 56 400
Liliana Ercole Spain 11 127 0.6× 97 0.8× 82 1.2× 58 0.9× 56 0.9× 14 433
Géza Simon United States 17 395 1.9× 132 1.1× 82 1.2× 132 2.1× 117 1.8× 50 702
Nobuo Irokawa Japan 11 118 0.6× 85 0.7× 78 1.1× 156 2.4× 42 0.7× 35 425
Lucia Turolo Italy 10 232 1.1× 84 0.7× 48 0.7× 166 2.6× 23 0.4× 27 400

Countries citing papers authored by Lawrence Levine

Since Specialization
Citations

This map shows the geographic impact of Lawrence Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Levine more than expected).

Fields of papers citing papers by Lawrence Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Levine. The network helps show where Lawrence Levine may publish in the future.

Co-authorship network of co-authors of Lawrence Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Levine. A scholar is included among the top collaborators of Lawrence Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Levine. Lawrence Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Levine, Lawrence. (1998). Proteolysis Negatively Regulates Agonist-Stimulated Arachidonic Acid Metabolism. Cellular Signalling. 10(9). 653–659. 9 indexed citations
2.
Levine, Lawrence & Yuzuru Shimizu. (1992). Antibodies to brevetoxin B: Serologic differentiation of brevetoxin B and brevetoxin A. Toxicon. 30(4). 411–418. 11 indexed citations
3.
Yatsunami, Jun, Hirota Fujiki, Masami Suganuma, et al.. (1991). Binding competition of okadaic acid derivatives to anti-okadaic acid antibody. Toxicon. 29(11). 1409–1412. 2 indexed citations
4.
Tashjian, Armen H., et al.. (1988). Use of Minoxidil to Demonstrate that Prostacyclin is not the Mediator of Bone Resorption Stimulated by Growth Factors in Mouse Calvariae*. Endocrinology. 123(2). 969–974. 4 indexed citations
5.
Krausz, Michael M., et al.. (1982). Thromboxane Mediation of Cardiopulmonary Effects of Embolism. Journal of Clinical Investigation. 70(2). 361–368. 56 indexed citations
6.
Swartz, Stephen L., Gordon H. Williams, Norman K. Hollenberg, et al.. (1980). Captopril-induced Changes in Prostaglandin Production. Journal of Clinical Investigation. 65(6). 1257–1264. 288 indexed citations
7.
Zuckerman, James, et al.. (1970). Rapid, Quantitative Estimation of Human Placental Lactogen in Maternal Serum by Complement Fixation. The Journal of Clinical Endocrinology & Metabolism. 30(6). 769–773. 13 indexed citations
8.
Munson, Paul L., Armen H. Tashjian, & Lawrence Levine. (1965). Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia.. PubMed. 25(7). 1062–7. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026